Display options
Cite
Livrinova V, Lega MH, Dimcheva AH, et al. Factor V Leiden, Prothrombin and MTHFR Mutation in Patients with Preeclamsia, Intrauterine Growth Restriction and Placental Abruption. Open Access Maced J Med Sci. 2015;3(4):590-4doi: 10.3889/oamjms.2015.099.
Livrinova, V., Lega, M. H., Dimcheva, A. H., Samardziski, I., & Isjanovska, R. (2015). Factor V Leiden, Prothrombin and MTHFR Mutation in Patients with Preeclamsia, Intrauterine Growth Restriction and Placental Abruption. Open access Macedonian journal of medical sciences, 3(4), 590-4. https://doi.org/10.3889/oamjms.2015.099
Livrinova, Vesna, et al. "Factor V Leiden, Prothrombin and MTHFR Mutation in Patients with Preeclamsia, Intrauterine Growth Restriction and Placental Abruption." Open access Macedonian journal of medical sciences vol. 3,4 (2015): 590-4. doi: https://doi.org/10.3889/oamjms.2015.099
Livrinova V, Lega MH, Dimcheva AH, Samardziski I, Isjanovska R. Factor V Leiden, Prothrombin and MTHFR Mutation in Patients with Preeclamsia, Intrauterine Growth Restriction and Placental Abruption. Open Access Maced J Med Sci. 2015 Dec 15;3(4):590-4. doi: 10.3889/oamjms.2015.099. Epub 2015 Sep 18. PMID: 27275292; PMCID: PMC4877892.
Copy Download .nbib Format: NLM
Share it on

Open Access Maced J Med Sci. 2015 Dec 15;3(4):590-4. doi: 10.3889/oamjms.2015.099. Epub 2015 Sep 18.

Factor V Leiden, Prothrombin and MTHFR Mutation in Patients with Preeclamsia, Intrauterine Growth Restriction and Placental Abruption.

Open access Macedonian journal of medical sciences

Vesna Livrinova, Marija Hadzi Lega, Anita Hristova Dimcheva, Igor Samardziski, Rozalinda Isjanovska

Affiliations

  1. University Clinic for Obstetrics and Gynecology, Faculty of Medicine, Ss. Cyril and Methodius University of Skopje, Skopje, Republic of Macedonia.
  2. Institute for Transfusion Medicine, Faculty of Medicine, Ss. Cyril and Methodius University of Skopje, Skopje, Republic of Macedonia.
  3. Institute for Epidemiology and Medical Biostatistics, Faculty of Medicine, Ss. Cyril and Methodius University of Skopje, Skopje, Republic of Macedonia.

PMID: 27275292 PMCID: PMC4877892 DOI: 10.3889/oamjms.2015.099

Abstract

BACKGROUND: Factor V Leiden, Prothrombin and MTHFR gene mutation, could have an influence in pregnancy with adverse outcome Preeclamsia, IUGR and Placental abruption.

AIM: The aim of this study is to investigate the presence of above mentioned inherited thrombophilias and its statistical significance, distribution among the complicated and normal pregnancy, and relative risk for carrier of mutation to develop preeclampsia, IUGR and placental abruption.

MATERIAL AND METHODS: Prospective cohort study is implemented at University Clinic for Obstetric and Gynecology in Skopje, Republic of Macedonia. The study included 109 delivered patients: 40 with preeclapmsia, 22 with IUGR, 17 with placental abruption and 30 as control group with normal pregnancy. The amount of 3 ml venous blood has been used for detection of these point mutations using ThromboStrip -Opegen, QIAGEN kit manufactured for thrombotic risk.

RESULTS: The highest frequency was found: in the group with preeclampsia 35% were MTHFR homozygous, IUGR -MTHFR heterozygous 45%, Placental abruption- 52.9% MTHFR heterozygous, and in the control group without thrombophilia 56.7%. There were combined thrombophilia in 3 patients. There aren`t statistical significance in presence of thrombophilia among groups (p > 0.05). Statistical significance (p < 0.05) was found between carriers of MTHFR homozygous in preeclampsia and group with placental abruption and control group. Relative risk in IUGR group for MTHFR homozygous was 5.54 (1.37

CONCLUSION: The presence of mutation MTHFR homozygous could increase the risk for development of IUGR and mutation of Factor V Leiden for placental abruption. Further investigations with more patients are warranted.

Keywords: IUGR; MTHFR; factor V Leiden; placental abruption; preeclampsia; prothrombin

References

  1. Am J Obstet Gynecol. 1998 Nov;179(5):1324-8 - PubMed
  2. Gynecol Obstet Invest. 2002;53(2):84-7 - PubMed
  3. Croat Med J. 2006 Jun;47(3):433-9 - PubMed
  4. Best Pract Res Clin Haematol. 2003 Jun;16(2):243-59 - PubMed
  5. Haemostasis. 1999;29(4):197-203 - PubMed
  6. Haematologica. 2001 Apr;86(4):428-31 - PubMed
  7. N Engl J Med. 2000 Feb 10;342(6):374-80 - PubMed
  8. Obstet Gynecol. 2001 Dec;98(6):1041-4 - PubMed
  9. Nature. 1994 May 5;369(6475):64-7 - PubMed
  10. Thromb Haemost. 1997 Jul;78(1):483-8 - PubMed
  11. N Engl J Med. 1999 Jan 7;340(1):9-13 - PubMed
  12. Eur J Obstet Gynecol Reprod Biol. 2004 Mar 15;113(1):36-40 - PubMed
  13. Haematologica. 2002 Oct;87(10):1095-108 - PubMed
  14. N Engl J Med. 2002 Jul 4;347(1):19-25 - PubMed
  15. N Engl J Med. 2001 Apr 19;344(16):1222-31 - PubMed
  16. Obstet Gynecol. 2005 Jan;105(1):182-92 - PubMed
  17. Am J Obstet Gynecol. 1997 Feb;176(2):457-60 - PubMed
  18. Hum Genet. 2001 Oct;109(4):369-84 - PubMed

Publication Types